ArticleClinical epigenetics2024

Blood-based HYAL2 methylation as a potential marker for the preclinical detection of coronary heart disease and stroke.

Lanfei Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.